Acecainide hydrochloride (NAPA) is the primary active hepatic metabolite of procainamide. It is used in cardiovascular research to study antiarrhythmic mechanisms and associated cardiotoxic risks, particularly under conditions like renal impairment. This compound is applied in both in vitro electrophysiology studies and in vivo pharmacological models.